Klingenstein Fields & CO LP Eli Lilly & CO Transaction History

Klingenstein Fields & CO LP

$2.32 Billion
Q1 2025

A detailed history of Klingenstein Fields & CO LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Klingenstein Fields & CO LP holds 101,555 shares of LLY stock, worth $77.8 Million. This represents 3.62% of its overall portfolio holdings.

Number of Shares

101,555

Previous 102,797 1.21%

Holding current value

$77.8 Million

Previous $79.4 Million 5.69%

% of portfolio

3.62%

Previous 3.24%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	SELL	$725.72 - $929.72 $901,344 - $1.15 Million	-1,242 Reduced 1.21%	101,555 $83.9 Million
Q4 2024 Jan 30, 2025	BUY	$727.2 - $932.06 $378,144 - $484,671	520 Added 0.51%	102,797 $79.4 Million
Q3 2024 Oct 29, 2024	BUY	$772.14 - $960.02 $6.65 Million - $8.27 Million	8,615 Added 9.2%	102,277 $90.6 Million
Q2 2024 Aug 01, 2024	SELL	$724.87 - $909.04 $829,976 - $1.04 Million	-1,145 Reduced 1.21%	93,662 $84.8 Million
Q1 2024 Apr 29, 2024	SELL	$592.2 - $792.28 $1.04 Million - $1.39 Million	-1,757 Reduced 1.82%	94,807 $73.8 Million
Q4 2023 Feb 01, 2024	SELL	$525.19 - $619.13 $607,119 - $715,714	-1,156 Reduced 1.18%	96,564 $56.3 Million
Q3 2023 Oct 27, 2023	SELL	$434.7 - $599.3 $18,257 - $25,170	-42 Reduced 0.04%	97,720 $52.5 Million
Q2 2023 Aug 01, 2023	SELL	$350.74 - $468.98 $292,166 - $390,660	-833 Reduced 0.84%	97,762 $45.8 Million
Q1 2023 Apr 28, 2023	SELL	$310.63 - $364.82 $284,847 - $334,539	-917 Reduced 0.92%	98,595 $33.9 Million
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $589,401 - $686,770	-1,833 Reduced 1.81%	99,512 $36.4 Million
Q3 2022 Oct 28, 2022	SELL	$296.48 - $337.87 $741,200 - $844,675	-2,500 Reduced 2.41%	101,345 $32.8 Million
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $275,663 - $323,670	-989 Reduced 0.94%	103,845 $33.7 Million
Q1 2022 Apr 27, 2022	SELL	$234.69 - $291.66 $320,821 - $398,699	-1,367 Reduced 1.29%	104,834 $30 Million
Q4 2021 Jan 31, 2022	SELL	$224.85 - $279.04 $1.1 Million - $1.37 Million	-4,910 Reduced 4.42%	106,201 $29.3 Million
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $440,319 - $541,874	-1,987 Reduced 1.76%	111,111 $25.7 Million
Q2 2021 Jul 26, 2021	SELL	$180.55 - $233.54 $91,899 - $118,871	-509 Reduced 0.45%	113,098 $26 Million
Q1 2021 Apr 29, 2021	SELL	$164.32 - $212.72 $200,306 - $259,305	-1,219 Reduced 1.06%	113,607 $21.2 Million
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $52,184 - $69,052	-400 Reduced 0.35%	114,826 $19.4 Million
Q3 2020 Oct 30, 2020	SELL	$146.22 - $169.13 $413,802 - $478,637	-2,830 Reduced 2.4%	115,226 $17.1 Million
Q2 2020 Aug 03, 2020	SELL	$136.42 - $164.18 $196,717 - $236,747	-1,442 Reduced 1.21%	118,056 $19.4 Million
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $77,382 - $95,777	-650 Reduced 0.54%	119,498 $16.6 Million
Q4 2019 Feb 04, 2020	SELL	$106.92 - $132.43 $4,383 - $5,429	-41 Reduced 0.03%	120,148 $15.8 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $16,507 - $19,268	-149 Reduced 0.12%	120,189 $13.3 Million
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $20.8 Million - $24.5 Million	-187,248 Reduced 60.88%	120,338 $15.6 Million
Q4 2018 Jan 22, 2019	SELL	$105.9 - $118.64 $58,668 - $65,726	-554 Reduced 0.18%	307,586 $35.6 Million
Q3 2018 Nov 01, 2018	SELL	$85.86 - $107.31 $661,122 - $826,287	-7,700 Reduced 2.44%	308,140 $33.1 Million
Q1 2018 May 01, 2018	SELL	$74.21 - $87.6 $85,341 - $100,740	-1,150 Reduced 0.36%	315,840 $24.4 Million
Q4 2017 Jan 30, 2018	SELL	$81.94 - $87.89 $127,007 - $136,229	-1,550 Reduced 0.49%	316,990 $26.8 Million
Q3 2017 Nov 01, 2017	BUY	$77.07 - $85.54 $24.5 Million - $27.2 Million	318,540	318,540 $27.2 Million

Others Institutions Holding LLY

# of Institutions

4,393

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $728B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingenstein Fields & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Klingenstein Fields & CO LP with notifications on news.

Account

Klingenstein Fields & CO LP Eli Lilly & CO Transaction History